March 25, 2014 — ZyCal Bioceuticals Healthcare Company recently announced that it is expanding to a new state-of-the-art GMP certified 5,000 sq. ft. manufacturing facility and corporate headquarters, positioning the company for increased capabilities and future growth. Manufacturing excellence and the highest standards of quality control are fundamental principles in ZyCal’s non-GMO, BSE-free production process.
This is the third expansion in the past five years for ZyCal Bioceuticals Healthcare Company, as their business continues to grow, bringing economic and employment opportunity to central New Jersey.
According to CEO and President, James J. Scaffidi, “ZyCal Bioceuticals Healthcare Company is one of the fastest growing healthcare companies, committed to manufacturing cutting-edge, premium, bio-active protein-based nutritional ingredients focused on bone and joint health. We have faced the economic downturn in the market with strong growth thanks to our innovative product offerings and successful partnerships with other companies which share our commitment to quality and premium product offerings. Through our leadership position in science and clinical trials, ZyCal has been able to position Cyplexinol as the ingredient of choice for both healthcare professionals and consumer companies.”
ZyCal Bioceuticals Healthcare Company manufactures premium nutritional bone and joint ingredients and supplements that enrich people’s lives. The company is committed to providing superior products and services to healthcare providers and their patients as well as consumers seeking a better quality of life.